Apr 2, 2024, 05:10
Chul Kim: March has been fruitful and rewarding, as we launched two IITs of ADC back to back!
Chul Kim, Thoracic Medical Oncologist at Georgetown University, shared on X/Twitter:
“March has been fruitful and rewarding, as we launched two IITs of ADC back to back!
1. Vobramitamab duocarmazine (B7-H3 ADC) for ES-SCLC, inclusive of patients with transformed SCLC (NCT06227546),
2. Sacituzumab govitecan for thymic epithelial tumors (NCT06248515).”
Source: Chul Kim/X
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 21, 2024, 12:18
Dec 21, 2024, 11:52
Dec 21, 2024, 11:30
Dec 21, 2024, 11:25
Dec 21, 2024, 11:18